研究課題/領域番号 |
22K20705
|
研究種目 |
研究活動スタート支援
|
配分区分 | 基金 |
審査区分 |
0801:薬学およびその関連分野
|
研究機関 | 北海道大学 |
研究代表者 |
タン ロジャー・サルバシオン 北海道大学, 先端生命科学研究院, 助教 (10951759)
|
研究期間 (年度) |
2022-08-31 – 2024-03-31
|
研究課題ステータス |
中途終了 (2023年度)
|
配分額 *注記 |
2,860千円 (直接経費: 2,200千円、間接経費: 660千円)
2023年度: 1,430千円 (直接経費: 1,100千円、間接経費: 330千円)
2022年度: 1,430千円 (直接経費: 1,100千円、間接経費: 330千円)
|
キーワード | Exosome / Nanosome / Drug Delivery System / Nanoparticles / Exosome-nanosme / Cancer cells / Nanoparticle |
研究開始時の研究の概要 |
Part 1: Exosome target organ determination. Part 2: Nanosome construction and Drug loading. Part 3: Efficiency testing of the novel platform.
|
研究実績の概要 |
In the extracellular vesicles population produced by cells, exosomes only constitute a small portion of the population. This has been one of the limitations of studying exosomes. One of the optimization protocols necessary and employed in this research was to find a way to induce the production of a higher number of exosomes in cancer cells. After employing different strategies, we were able to successfully induce cancer cells to produce a higher number of exosomes by starving them. Production and isolation of exosomes from starved cancer cells were then optimized to yield a stably high number of exosomes. Starved cancer cells produced a higher number of exosomes (1.56e+15 particles per mL with an average particle size of 139.5 nm) compared to the fed cancer cells (1.51e+10 particles per mL with an average particle size of 106.5 nm). This finding enabled us to optimize the exosome production and yielded considerably more exosomes needed for the study.
|